Dokumentumok
- Colonoscopy
- Targeted Diagnostics
- Booklets and publications in biotechnology
- Gastroscopy
- Professional Information
KPS PONT
Exposure to Low-Dose Ionizing Radiation from Medical Imaging Procedures
Background: The growing use of imaging procedures in the United States has raised concerns about exposure to low-dose ionizing radiation in the general population.
Methods: We identified 952,420 nonelderly adults (between 18 and 64 years of age) in five health care markets across the United States between January 1, 2005, and December 31, 2007. Utilization data were used to estimate cumulative effective doses of radiation from imaging procedures and to calculate population-based rates of exposure, with annual effective doses defined as low (3 mSv), moderate (>3 to 20 mSv), high (>20 to 50 mSv), or very high (>50 mSv).
Results: During the study period, 655,613 enrollees (68.8%) underwent at least one imaging procedure associated with radiation exposure. The mean (±SD) cumulative effective dose from imaging procedures was 2.4±6.0 mSv per enrollee per year; however, a wide distribution was noted, with a median effective dose of 0.1 mSv per enrollee per year (interquartile range, 0.0 to 1.7). Overall, moderate effective doses of radiation were incurred in 193.8 enrollees per 1000 per year, whereas high and very high doses were incurred in 18.6 and 1.9 enrollees per 1000 per year, respectively. In general, cumulative effective doses of radiation from imaging procedures increased with advancing age and were higher in women than in men. Computed tomographic and nuclear imaging accounted for 75.4% of the cumulative effective dose, with 81.8% of the total administered in outpatient settings.
Conclusions: Imaging procedures are an important source of exposure to ionizing radiation in the United States and can result in high cumulative effective doses of radiation.
Further news
- Molecular Diagnostic Center
- Capsule Endoscopy versus Colonoscopy for the Detection of Polyps and Cancer
- FDA: Cancer Warnings Required for TNF Blockers
- How Much Evidence Do We Need to Change Practices in Which We Firmly Believe?
- Aspirin Use and Survival After Diagnosis of Colorectal Cancer
- Colorectal anatomy in adults at computed tomography colonography: normal distribution and the effect
- Epigenomics AG: First Blood Test for Colorectal Cancer Available in Germany
- Detecting malignant lesions by endoscopy in 2741 primary care dyspeptic patients w/o alarm symptoms
- Meta-analysis: Can Helicobacter pylori Eradication Treatment Reduce the Risk for Gastric Cancer?
- The benefit of science TODAY
- Our publication has been released in Nature Reviews Drug Discovery
- Our genome sequencing lab is a part of the national r&d infrastructure network









